Anouk M E Jansen

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Peritoneal Dialysis

Clinical Practice

Protein Protein

Top Venues

Clinical pharmacokinetics

The Journal of antimicrobial chemotherapy

Medical mycology

This page only lists publications with an associated author ORCID identifier.

Publications

Anouk M E Jansen, Kim Snijdelaar, Ron J Keizer, Isabel Spriet, Erwin Dreesen, Roger J M Brüggemann, Rob Ter Heine
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole. Clinical pharmacokinetics 63 (5) (2024)
Anouk M E Jansen, Kim Snijdelaar, Ron J Keizer, Isabel Spriet, Erwin Dreesen, Roger J M Brüggemann, Rob Ter Heine
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole. Clinical pharmacokinetics (2024)
Anouk M E Jansen, Margot N Eggermont, Erik B Wilms, Sami Aziz, Monique Reijers, Jolt Roukema, Adilia Warris, Roger J M Brüggemann, Renske van der Meer
Evaluation of the drug-drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort. Medical mycology 62 (3) (2024)
Mehmet Ergün, Anouk M E Jansen, Luuk B Hilbrands, Elizabeth A de Kort, Henricus Kunst, Monique H E Reijers, Jeroen A Schouten, Paul E Verweij, Roger J M Brüggemann
Isavuconazole as prophylaxis and therapy for invasive fungal diseases: a real-life observational study. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Mehmet Ergün, Anouk M E Jansen, Luuk B Hilbrands, Elizabeth A de Kort, Henricus Kunst, Monique H E Reijers, Jeroen A Schouten, Paul E Verweij, Roger J M Brüggemann
Isavuconazole as prophylaxis and therapy for invasive fungal diseases: a real-life observational study. The Journal of antimicrobial chemotherapy (2024)
Anouk M E Jansen, Kim Snijdelaar, Ron J Keizer, Isabel Spriet, Erwin Dreesen, Roger J M Brüggemann, Rob Ter Heine
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole. Clinical pharmacokinetics 63 (5) (2024)
Anouk M E Jansen, Margot N Eggermont, Erik B Wilms, Sami Aziz, Monique Reijers, Jolt Roukema, Adilia Warris, Roger J M Brüggemann, Renske van der Meer
Evaluation of the drug-drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort. Medical mycology (2024)
Anouk M E Jansen, Margot N Eggermont, Erik B Wilms, Sami Aziz, Monique Reijers, Jolt Roukema, Adilia Warris, Roger J M Brüggemann, Renske van der Meer
Evaluation of the drug-drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort. Medical mycology 62 (3) (2024)
Anouk M E Jansen, Kim Snijdelaar, Ron J Keizer, Isabel Spriet, Erwin Dreesen, Roger J M Brüggemann, Rob Ter Heine
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole. Clinical pharmacokinetics 63 (5) (2024)
Mehmet Ergün, Anouk M E Jansen, Luuk B Hilbrands, Elizabeth A de Kort, Henricus Kunst, Monique H E Reijers, Jeroen A Schouten, Paul E Verweij, Roger J M Brüggemann
Isavuconazole as prophylaxis and therapy for invasive fungal diseases: a real-life observational study. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Anouk M E Jansen, Beatrijs Mertens, Isabel Spriet, Paul E Verweij, Jeroen A Schouten, Joost Wauters, Yves Debaveye, Rob Ter Heine, Roger J M Brüggemann
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies. Clinical pharmacokinetics (2023)
Anouk M E Jansen, Rob Ter Heine, Paul E Verweij, Roger J M Brüggemann
High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints. Clinical pharmacokinetics (2023)